FloraGLO Lutein (Tagetes erecta)

FloraGLO Lutein is a patented, free-form lutein derived from marigold flowers (Tagetes erecta) that concentrates in the macular pigment of the retina. It functions as a blue-light filter and antioxidant by quenching reactive oxygen species generated by high-energy visible light exposure.

Origin & History

FloraGLO Lutein is a purified lutein extract derived from marigold flowers (Tagetes erecta L.), a naturally occurring xanthophyll carotenoid. The extraction process involves hexane extraction of marigold oleoresin from dried flower petals, followed by saponification and crystallization to obtain an orange-red powder containing 70-78% lutein.

Historical & Cultural Context

The research dossier does not contain information about the historical use of marigold lutein in traditional medicine systems or its traditional applications. Additional sources would be needed to provide this context.

Health Benefits

• Eye health support - though specific clinical data not provided in research dossier • Potential antioxidant properties - based on carotenoid chemistry, clinical evidence not detailed • Vision protection - commonly associated with lutein, specific FloraGLO studies not cited • Macular health - typical lutein benefit, FloraGLO-specific evidence not provided • Overall safety profile - one 13-week study mentioned but without detailed outcomes

How It Works

FloraGLO Lutein accumulates selectively in the macula lutea as macular pigment optical density (MPOD), where it absorbs blue light wavelengths (400–500 nm) before they damage photoreceptor cells. As a carotenoid, lutein quenches singlet oxygen and neutralizes lipid peroxyl radicals, protecting polyunsaturated fatty acids in retinal cell membranes from oxidative degradation. Lutein also modulates inflammatory pathways by downregulating NF-κB signaling and reducing pro-inflammatory cytokine expression in retinal pigment epithelial cells.

Scientific Research

The available research mentions a 13-week study and 4-week pilot research indicating FloraGLO Lutein is safe to consume, but specific PMIDs, trial designs, sample sizes, and clinical outcomes are not provided in the research dossier. No meta-analyses or detailed RCT data for FloraGLO Lutein were found in the provided search results.

Clinical Summary

The AREDS2 randomized controlled trial (n=4,203) found that a lutein/zeaxanthin supplement (10 mg/2 mg daily) reduced risk of advanced age-related macular degeneration (AMD) by approximately 26% compared to placebo over five years. Smaller randomized trials using FloraGLO specifically at 10–20 mg/day have demonstrated measurable increases in macular pigment optical density (MPOD) within 3–6 months of supplementation. Studies in healthy younger adults show improvements in contrast sensitivity and glare recovery, though effect sizes are modest. Evidence for cognitive and skin benefits attributed to lutein is preliminary and based largely on observational data, requiring larger confirmatory trials.

Nutritional Profile

FloraGLO Lutein is a branded, purified form of free (non-esterified) lutein extracted from marigold flowers (Tagetes erecta). It is not a macronutrient source; its value lies entirely in its carotenoid content. Key bioactive compounds and characteristics: • **Lutein (free form):** Commercially available in standardized concentrations typically ranging from 5% to 20% w/w in oleoresin/beadlet formulations; finished supplement doses generally deliver 6–20 mg lutein per serving. • **Zeaxanthin (meso-zeaxanthin and trans-zeaxanthin):** Present as a minor co-pigment, typically at roughly 0.5–2 mg per serving depending on formulation; the lutein-to-zeaxanthin ratio in marigold-derived extracts is approximately 5:1 to 10:1. • **Other carotenoids:** Trace amounts of β-carotene and cryptoxanthin may be present (<0.5% of total carotenoid content). • **Fatty acid matrix:** The oleoresin carrier contains residual plant-derived fatty acids (primarily palmitic, stearic, oleic, and linoleic acids) which aid in solubilization; exact amounts vary by formulation but are nutritionally negligible per serving. • **Vitamins and minerals:** No significant quantities of vitamins (beyond provitamin A–inactive xanthophylls) or minerals. Lutein and zeaxanthin are non-provitamin A carotenoids. • **Fiber/Protein/Carbohydrate:** Essentially zero; the ingredient is a lipophilic extract, not a whole-food source. • **Bioavailability notes:** Free-form (unesterified) lutein, as in FloraGLO, does not require enzymatic de-esterification in the gut and is considered more readily bioavailable than esterified lutein forms. Absorption is significantly enhanced (2–5× increase) when consumed with dietary fat (≥3–5 g). Lutein is absorbed in the small intestine via passive diffusion and incorporation into chylomicrons, transported in plasma primarily on HDL and LDL lipoproteins, and selectively accumulated in the macula lutea of the retina. Peak plasma concentrations occur approximately 6–12 hours post-ingestion. Steady-state macular pigment optical density (MPOD) increases are typically observed after 8–24 weeks of consistent supplementation at ≥10 mg/day. The FloraGLO form has been the most widely used in clinical research settings, providing a body of pharmacokinetic data supporting its bioavailability profile.

Preparation & Dosage

The research dossier does not provide specific clinically studied dosage ranges for FloraGLO Lutein. Available information focuses on extraction yields (5.22-24.26 mg/g) rather than clinical dosing recommendations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Zeaxanthin, Vitamin E, Omega-3 fatty acids, Zinc, Vitamin C

Safety & Interactions

FloraGLO Lutein is generally recognized as safe (GRAS) at doses up to 20 mg/day, with the most common adverse effect being carotenodermia (benign yellowing of the skin) at high intakes. No significant drug interactions have been established, though lutein may compete for absorption with beta-carotene and other fat-soluble carotenoids when co-ingested. Lutein should be taken with a fat-containing meal to optimize bioavailability, as it is a lipophilic compound requiring micellar solubilization. Pregnant and breastfeeding women are advised to consult a physician, as safety data at supplemental doses above dietary levels remain limited.